Cargando…

The relationship between obesity and diabetic nephropathy in China

BACKGROUND: The epidemic of diabetic nephropathy (DN) has been paralleled by rapid increases in both obesity and diabetes in China. The aim of this study was to investigate the natural history of DN and the association of obesity and renal function with diabetes. METHODS: In total, 264 patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hui-Mei, Shen, Wen-Wen, Ge, Yong-Chun, Zhang, Yi-De, Xie, Hong-Lang, Liu, Zhi-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614546/
https://www.ncbi.nlm.nih.gov/pubmed/23521842
http://dx.doi.org/10.1186/1471-2369-14-69
_version_ 1782264860941221888
author Chen, Hui-Mei
Shen, Wen-Wen
Ge, Yong-Chun
Zhang, Yi-De
Xie, Hong-Lang
Liu, Zhi-Hong
author_facet Chen, Hui-Mei
Shen, Wen-Wen
Ge, Yong-Chun
Zhang, Yi-De
Xie, Hong-Lang
Liu, Zhi-Hong
author_sort Chen, Hui-Mei
collection PubMed
description BACKGROUND: The epidemic of diabetic nephropathy (DN) has been paralleled by rapid increases in both obesity and diabetes in China. The aim of this study was to investigate the natural history of DN and the association of obesity and renal function with diabetes. METHODS: In total, 264 patients with renal biopsy-confirmed DN were examined from 2002 to 2008 and followed up to June 2008 in our institute. Among these, 129 patients were classified into a Kidney Disease Outcomes Quality Initiative (K/DOQI) stage I subgroup. Weight status, clinico-histopathological features, the development of end-stage renal disease (ESRD) and increased proteinuria were evaluated at the baseline of biopsy and during the follow up. Lean, overweight and obese phenotypes were defined as body mass index (BMI) less than 25 kg/m(2), 25–28 kg/m(2), and more than 28 kg/m(2) over, respectively. RESULTS: In the patients with renal biopsy-confirmed DN, BMI was 25.5 ± 3.39 kg/m(2), with 122 (46.2%), 83 (31.4%) and 59 (22.3%) having lean, overweight and obese phenotypes, respectively. Mean proteinuria was 3.09 ± 2.32 g/24 h, serum creatinine was 2.02 ± 2.02 mg/dL, and creatinine clearance rate (Ccr) was 96.0 ± 54.0 mL/min/1.73 m(2). Compared with obese patients, lean patients had a lower Ccr, a higher percentage of anemia, more renal lesions and higher risk for ESRD (HR = 1.812, P = 0.048). The weight in obese patients decreased significantly after 27 months, and lean patients had a longer duration of diabetes than obese patients. Regarding patients at K/DOQI stage I, patients with DN showed similar duration of diabetes regardless of weight status. Minimal weight loss was recorded in obese patients during follow-up, and they exhibited greater glomerular hyperfiltration and higher risk for increased proteinuria (HR = 2.872, P = 0.014) than lean patients. CONCLUSIONS: In China, obesity is common in DN patients undergoing biopsy. Initial high levels of proteinuria and subsequent weight loss are the major characteristics of the natural course of DN. Obesity contributed to increased proteinuria at an early stage, while the lean phenotype was associated with ESRD development, especially at the later stages.
format Online
Article
Text
id pubmed-3614546
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36145462013-04-03 The relationship between obesity and diabetic nephropathy in China Chen, Hui-Mei Shen, Wen-Wen Ge, Yong-Chun Zhang, Yi-De Xie, Hong-Lang Liu, Zhi-Hong BMC Nephrol Research Article BACKGROUND: The epidemic of diabetic nephropathy (DN) has been paralleled by rapid increases in both obesity and diabetes in China. The aim of this study was to investigate the natural history of DN and the association of obesity and renal function with diabetes. METHODS: In total, 264 patients with renal biopsy-confirmed DN were examined from 2002 to 2008 and followed up to June 2008 in our institute. Among these, 129 patients were classified into a Kidney Disease Outcomes Quality Initiative (K/DOQI) stage I subgroup. Weight status, clinico-histopathological features, the development of end-stage renal disease (ESRD) and increased proteinuria were evaluated at the baseline of biopsy and during the follow up. Lean, overweight and obese phenotypes were defined as body mass index (BMI) less than 25 kg/m(2), 25–28 kg/m(2), and more than 28 kg/m(2) over, respectively. RESULTS: In the patients with renal biopsy-confirmed DN, BMI was 25.5 ± 3.39 kg/m(2), with 122 (46.2%), 83 (31.4%) and 59 (22.3%) having lean, overweight and obese phenotypes, respectively. Mean proteinuria was 3.09 ± 2.32 g/24 h, serum creatinine was 2.02 ± 2.02 mg/dL, and creatinine clearance rate (Ccr) was 96.0 ± 54.0 mL/min/1.73 m(2). Compared with obese patients, lean patients had a lower Ccr, a higher percentage of anemia, more renal lesions and higher risk for ESRD (HR = 1.812, P = 0.048). The weight in obese patients decreased significantly after 27 months, and lean patients had a longer duration of diabetes than obese patients. Regarding patients at K/DOQI stage I, patients with DN showed similar duration of diabetes regardless of weight status. Minimal weight loss was recorded in obese patients during follow-up, and they exhibited greater glomerular hyperfiltration and higher risk for increased proteinuria (HR = 2.872, P = 0.014) than lean patients. CONCLUSIONS: In China, obesity is common in DN patients undergoing biopsy. Initial high levels of proteinuria and subsequent weight loss are the major characteristics of the natural course of DN. Obesity contributed to increased proteinuria at an early stage, while the lean phenotype was associated with ESRD development, especially at the later stages. BioMed Central 2013-03-25 /pmc/articles/PMC3614546/ /pubmed/23521842 http://dx.doi.org/10.1186/1471-2369-14-69 Text en Copyright © 2013 Chen et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Chen, Hui-Mei
Shen, Wen-Wen
Ge, Yong-Chun
Zhang, Yi-De
Xie, Hong-Lang
Liu, Zhi-Hong
The relationship between obesity and diabetic nephropathy in China
title The relationship between obesity and diabetic nephropathy in China
title_full The relationship between obesity and diabetic nephropathy in China
title_fullStr The relationship between obesity and diabetic nephropathy in China
title_full_unstemmed The relationship between obesity and diabetic nephropathy in China
title_short The relationship between obesity and diabetic nephropathy in China
title_sort relationship between obesity and diabetic nephropathy in china
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614546/
https://www.ncbi.nlm.nih.gov/pubmed/23521842
http://dx.doi.org/10.1186/1471-2369-14-69
work_keys_str_mv AT chenhuimei therelationshipbetweenobesityanddiabeticnephropathyinchina
AT shenwenwen therelationshipbetweenobesityanddiabeticnephropathyinchina
AT geyongchun therelationshipbetweenobesityanddiabeticnephropathyinchina
AT zhangyide therelationshipbetweenobesityanddiabeticnephropathyinchina
AT xiehonglang therelationshipbetweenobesityanddiabeticnephropathyinchina
AT liuzhihong therelationshipbetweenobesityanddiabeticnephropathyinchina
AT chenhuimei relationshipbetweenobesityanddiabeticnephropathyinchina
AT shenwenwen relationshipbetweenobesityanddiabeticnephropathyinchina
AT geyongchun relationshipbetweenobesityanddiabeticnephropathyinchina
AT zhangyide relationshipbetweenobesityanddiabeticnephropathyinchina
AT xiehonglang relationshipbetweenobesityanddiabeticnephropathyinchina
AT liuzhihong relationshipbetweenobesityanddiabeticnephropathyinchina